Motexafin gadolinium (MGd) combined with whole-brain irradiation therapy prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis of two randomized phase 3 trials Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Shapiro, WR
  • Mehta, MP
  • Patchell, RA
  • Glantz, MJ
  • Recht, L
  • Sur, Ranjan
  • Fortin, A
  • Ung, Y
  • Souhami, L
  • Phan, S
  • Smith, JA
  • Renschler, MF

publication date

  • October 2006